This post is sponsored by BioNJ.

BioNJ, the trade association for New Jerseys biotechnology industry, will host its biggest and most interactive event to date for companies involved in diagnostics and personalized medicine on March 14 at Princeton University. The BioNJ Diagnostics & Personalized Medicine Innovation Summit and Funding Roundtable, part of BioNJs ongoing Diagnostics & Personalized Medicine Initiative, will bring together leaders from major global biotechnology and pharmaceutical companies, diagnostics companies and emerging innovator companies for a half-day, interactive summit meeting.

The focus of this half-day summit is to help participants identify opportunities for partnership, funding and growth while updating them on the latest trends, developments and challenges in the evolution and adoption of personalized medicine. All companies and individuals with an interest in diagnostics and personalized medicine are welcome to attend. The Summit will include company presentations and opportunities for one-on-one communication and interaction between leading global pharmaceutical companies, emerging diagnostics companies, funding organizations and life sciences company business development professionals.

This event promises to be truly unique for those who attend, said Debbie Hart, President of BioNJ. Not only have we confirmed first-class speakers from all key constituencies involved with diagnostics and personalized medicine, we will also create opportunities for global life science leaders, smaller innovators and members of the investment community to network and establish partnerships that will advance the development and utilization of personalized medicine worldwide.

Speaking at the Summit will be leaders from the global investment community, global life sciences companies and academia:

The BioNJ Diagnostics and Personalized Medicine Committee, which created the event, is planning additional events focusing on diagnostics and personalized medicine, and will announce details for future events on its website.

The increasing interest in diagnostics and personalized medicine, and its potential to transform medicine, is clear from the participation in the events that the BioNJ Diagnostics and Personalized Medicine Committee has offered so far, said Steve Carchedi, Committee Co-Chair, Chief Marketing Officer, Medical Diagnostics, GE Healthcare. The BioNJ Diagnostics & Personalized Medicine Innovation Summit and Funding Roundtable will be our biggest event ever, and I encourage anyone with an interest in diagnostics and personalized medicine to join us on March 14th at Princeton University, he added.

See the original post here:
BioNJ Diagnostics & Personalized Medicine Innovation Summit is March 14

Comments are closed.